MRFF Congenital Heart Disease

Up to $10M is available from MRFF Congenital Heart Disease to support research to reduce the impact of  congenital heart disease.


MRFF Congenital Heart Disease

The Congenital Heart Disease (CHD) grant opportunity forms part of the Accelerated Research initiative, funded through the Medical Research Future Fund (MRFF). This grant opportunity supports research to provide new diagnoses and treatment options for those suffering from congenital heart disease.

The MRFF Congenital Heart Disease was first announced on 14 February 2019 and is part of the Mission for Cardiovascular Health.



For this grant opportunity $20 million is available over 5 years from 2019-20 to 2023-24.

  • There is no minimum grant amount.
  • The maximum grant amount is $10 million.
  • The grant amount will be up to 100 per cent of eligible project costs.
  • You must complete your project by 30 June 2024.


Eligible Projects

Ideally projects will align with  the National Strategic Action Plan for Childhood Heart Disease, and could target the Research Priorities in the Action Plan in particular:

  • preventing neurodevelopmental and mental health complications
  • understanding the impact of prenatal and postnatal factors affecting the health of children born with CHD and their families, or
  • exploring the role of exercise and increased activity in reducing the impact of CHD.

You must ensure new research is complementary to, and does not duplicate work in the following MRFF Accelerated Research Investments:

  • The Stem Cells Australia research study into development of human heart tissue for understanding heart disease, improving repair and reconstructing tissues for kids with heart defects.
  • The Murdoch Children’s Research Institute project to enable the Australian Genomics Health Alliance to extend the Cardiovascular Genetic Disorders Flagship study, which aims to interrogate the genomic basis of disease in individuals and families with cardiomyopathies, arrhythmias and congenital heart disease.


Eligible Applicants

To be eligible you must:

  • have an Australian Business Number (ABN)
  • be incorporated in Australia
  • and, in accordance with s24 of the Medical Research Future Fund Act 2015, you must be one of the following eligible bodies:
    • a medical research institute
    • a university
    • a corporate Commonwealth entity
    • a corporation (including businesses and not for profits).

Joint applications are encouraged, provided you have a lead applicant who is the main driver of the project and is eligible to apply. For further information on joint applications, refer to the grant opportunity guidelines.



Applications close 12 September 2019.


More Information

What is the #1 grant for start-ups?

12,000+ companies access the R&D tax incentive per year that yields a CASH REBATE of up to 43.5%.
This might be perfect your start up.
Do you want to know more?

Scroll to Top
R&D Top 10 Consultant Tips

Top 10 Consultant Tips to Maximise the R&D Tax Incentive